Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Cefdinir" patented technology

Cefdinir is used to treat a wide variety of bacterial infections.

Packaging box (Cefdinir Dispersible Tablets 2)

ActiveCN310068099SCefdinirDispersible tablet
1. Name of the product in this design: Packaging Box (Cefdinir Dispersible Tablets 2). 2. Purpose of this design: Product packaging. 3. The key design elements of this product are the combination of shape, pattern, and color. 4. The image or photograph that best illustrates the design's key points: the front view. 5. The design for which protection is sought includes color.
Owner:TIANJIN HUAJIN PHARMA

Antibiotic combination therapy

The present invention provides antibiotic combination therapies for treating Acinetobacter baumannii infection in a subject. These combination therapies comprise rifudine and a second antibiotic such as colistin and cefdinir.
Owner:BIOVERSYS AG

Packaging box (Cefdinir Dispersible Tablets 3)

ActiveCN310068101SCefdinirDispersible tablet
1. Name of the product in this design: Packaging Box (Cefdinir Dispersible Tablets 3). 2. Purpose of this design: Product packaging. 3. The key design elements of this product are the combination of shape, pattern, and color. 4. The image or photograph that best illustrates the design's key features: the front view. 5. The design for which protection is sought includes color.
Owner:TIANJIN HUAJIN PHARMA

Combined auxiliary material applied to cefdinir preparation as well as preparation method and application of combined auxiliary material

The invention relates to the field of medicines, and particularly discloses a combined auxiliary material applied to a cefdinir preparation as well as a preparation method and application of the combined auxiliary material. The combined auxiliary material applied to the cefdinir preparation is prepared from the following raw materials in parts by weight: 1 to 3 parts of polyoxyl 40 stearate, 50 to 150 parts of microcrystalline cellulose, 0.03 to 0.05 part of colloidal silicon dioxide, 1 to 3 parts of 2-hydroxyethyl methacrylate, 3 to 5 parts of lactose and 0.5 to 0.8 part of medicinal adhesive. According to the invention, excessive microcrystalline cellulose is compounded with a small amount of polyoxyl 40 stearate, lactose and colloidal silicon dioxide, so that the dispersibility of polyoxyl 40 stearate in the combined auxiliary material is enhanced, the phenomenon of sticking caused by too high concentration of polyoxyl 40 stearate in a pharmaceutical preparation is reduced, and the dissolution rate of the medicine is improved.
Owner:JIANGSU YABANG QIANGSHENG PHARMA

Application of dihydrochalcone ferrous ion complex in food-borne microorganism resistance

The invention belongs to the field of medicinal chemistry, and discloses an application of a ferrous ion complex of dihydrochalcone compounds (phlorizin, PHL) and trilobatin, TLB) in prevention and treatment of food-borne microorganisms, and a preparation method of the ferrous ion complex of the dihydrochalcone compounds (phlorizin, PHL) and the trilobatin, TLB). The phlorizin-ferrous ion complex and the trilobatin-ferrous ion complex have relatively good DPPH (1, 1-diphenyl-2-picrylhydrazyl) scavenging capacity and hydroxyl radical scavenging capacity; the phlorizin-ferrous ion complex and the trilobatin-ferrous ion complex can slow down oxidation of edible oil and fat; the phlorizin-ferrous ion complex and the trilobatin-ferrous ion complex have different inhibitory activities on the tested food-borne microorganisms; when the compound is combined with the cefdinir for use, the phlorizin-ferrous ion and trilobatin-ferrous ion complexes can synergistically promote the antibacterial effect of the cefdinir, and the use dosage of the cefdinir is reduced. The two have the potential of being further researched and developed into a novel edible antibacterial agent.
Owner:LANZHOU UNIV

Method for smoking cessation

A method of treating a subject for smoking cessation including periodically administering to the subject a pharmaceutically effective amount of cefdinir to treat the subject. Cefdinir for use in treating a subject for smoking cessation. A pharmaceutical composition including a pharmaceutically effective amount of cefdinir for use in treating a subject for smoking cessation.
Owner:CALISTA CAPITAL LLC